Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy, safety and tolerability of prophylactic (preventative)
treatment with BOTOX® (onabotulinumtoxinA) compared to topiramate in adults with chronic
migraine.
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA Topiramate